Published in Immunology on November 01, 1993
Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev (2003) 2.03
Deletion of purE attenuates Brucella melitensis infection in mice. Infect Immun (1996) 1.88
Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect Immun (1995) 1.70
Interleukin-10 downregulates protective immunity to Brucella abortus. Infect Immun (1995) 1.68
Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages. Infect Immun (1998) 1.48
Differential activation of Brucella-reactive CD4+ T cells by Brucella infection or immunization with antigenic extracts. Infect Immun (1995) 1.33
A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect Immun (2002) 1.11
Effects of exogenous recombinant interleukin-12 on immune responses and protection against Brucella abortus in a murine model. Can J Vet Res (2001) 1.06
Differential induction of macrophage-derived cytokines by live and dead intracellular bacteria in vitro. Infect Immun (1995) 1.01
Characterization, occurrence, and molecular cloning of a 39-kilodalton Brucella abortus cytoplasmic protein immunodominant in cattle. Infect Immun (1997) 0.99
Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection. Infect Immun (2001) 0.97
Immune responses and resistance to brucellosis in mice vaccinated orally with Brucella abortus RB51. Infect Immun (1996) 0.91
Recombinant L7/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells. Immunology (1994) 0.91
TLR2 and TLR4 signaling pathways are required for recombinant Brucella abortus BCSP31-induced cytokine production, functional upregulation of mouse macrophages, and the Th1 immune response in vivo and in vitro. Cell Mol Immunol (2014) 0.88
Comparison of cytokine immune responses to Brucella abortus and Yersinia enterocolitica serotype O:9 infections in BALB/c mice. Infect Immun (2013) 0.80
Comparison of a classical Th1 bacteria versus a Th17 bacteria as adjuvant in the induction of experimental autoimmune encephalomyelitis. J Neuroimmunol (2011) 0.79
Adrenal steroids modulate the immune response during Brucella abortus infection by a mechanism that depends on the regulation of cytokine production. Infect Immun (2015) 0.78
Expression of cytokine and apoptosis-related genes in bovine peripheral blood mononuclear cells stimulated with Brucella abortus recombinant proteins. Vet Res (2016) 0.78
Either B7-1 or B7-2 is required for Listeria monocytogenes-specific production of gamma interferon and interleukin-2. Infect Immun (1996) 0.77
Subcellular fractions of Brucella ovis distinctively induce the production of interleukin-2, interleukin-4, and interferon-gamma in mice. Can J Vet Res (2005) 0.77
Changes in TNF and IL-6 production after diphtheria toxoid vaccination: drug modulation of the cytokine levels. Mediators Inflamm (1996) 0.75
Brucella and Osteoarticular Cell Activation: Partners in Crime. Front Microbiol (2017) 0.75
Interleukin-12 has a role in mediating resistance of murine strains to Tyzzer's disease. Infect Immun (1998) 0.75
Comparison between Immunization Routes of Live Attenuated Salmonella Typhimurium Strains Expressing BCSP31, Omp3b, and SOD of Brucella abortus in Murine Model. Front Microbiol (2016) 0.75
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol (1989) 31.72
Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science (1987) 13.03
Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med (1989) 11.36
A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods (1986) 8.88
Interleukin-6: an overview. Annu Rev Immunol (1990) 7.48
Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection. Proc Natl Acad Sci U S A (1985) 7.15
Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur J Immunol (1984) 4.00
Evidence that tumor necrosis factor has an important role in antibacterial resistance. J Immunol (1989) 3.90
Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect Immun (1988) 3.79
Production of tumor necrosis factor during murine listeriosis. J Immunol (1987) 3.14
Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J Immunol (1989) 2.73
Effects of cytokines on intracellular growth of Brucella abortus. Infect Immun (1993) 2.33
Protection against Brucella abortus in mice with O-polysaccharide-specific monoclonal antibodies. Infect Immun (1986) 2.32
Regulation of T-cell activation: differences among T-cell subsets. Immunol Rev (1989) 2.08
Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect Immun (1988) 2.04
In vivo and in vitro effects of monoclonal antibody to Ly antigens on immunity to infection. Cell Immunol (1982) 1.97
Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction. J Immunol (1990) 1.81
A simple sensitive bioassay for interleukin-1 which is unresponsive to 10(3) U/ml of interleukin-2. J Immunol Methods (1987) 1.80
Type I IL-1 receptor blockade exacerbates murine listeriosis. J Immunol (1992) 1.78
Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol (1989) 1.76
Cloned L3T4+ T lymphocytes protect mice against Listeria monocytogenes by secreting IFN-gamma. J Immunol (1988) 1.73
Effects of gamma interferon and indomethacin in preventing Brucella abortus infections in mice. Infect Immun (1992) 1.55
Macrophage activation during experimental murine brucellosis: a basis for chronic infection. Infect Immun (1979) 1.54
IFN-gamma-producing ability as a possible marker for the protective T cells against Mycobacterium bovis BCG in mice. J Immunol (1992) 1.45
Cytokine response of T-cell subsets from Brucella abortus-infected mice to soluble Brucella proteins. Infect Immun (1993) 1.44
In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice. Infect Immun (1984) 1.44
Recombinant interleukin-6 protects mice against experimental bacterial infection. Infect Immun (1992) 1.41
Difference in the induction of macrophage interleukin-1 production between viable and killed cells of Listeria monocytogenes. Infect Immun (1990) 1.38
Dissociated development of T cells mediating delayed-type hypersensitivity and protective T cells against Listeria monocytogenes and their functional difference in lymphokine production. Infect Immun (1991) 1.21
Cytokine expression in vivo during murine listeriosis. Infection with live, virulent bacteria is required for monokine and lymphokine messenger RNA accumulation in the spleen. J Immunol (1992) 1.15
Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus. Infect Immun (1990) 1.10
Interleukin-1-induced promotion of T-cell differentiation in mice immunized with killed Listeria monocytogenes. Infect Immun (1990) 1.06
Immunogenicity of Brucella abortus salt-extractable proteins. Vet Microbiol (1989) 1.01
Prophylaxis or treatment of experimental brucellosis with interleukin-1. Infect Immun (1991) 1.00
Resistance and susceptibility of mice to bacterial infection. IV. Functional specificity in natural resistance to facultative intracellular bacteria. J Reticuloendothel Soc (1983) 0.90
Vaccination of cattle with chemically modified and unmodified salt-extractable proteins from Brucella abortus. Vet Microbiol (1987) 0.87
Anti-bacterial activity of peritoneal cells from transgenic mice producing high levels of GM-CSF. Immunology (1990) 0.83
A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity (2001) 9.45
Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J (1987) 7.45
Molecular cloning of cDNA encoding a murine haematopoietic growth regulator, granulocyte-macrophage colony stimulating factor. Nature (1984) 4.46
Activated macrophages in congenitally athymic "nude mice" and in lethally irradiate mice. J Immunol (1975) 3.96
Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis. Infect Immun (1978) 3.24
Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03
Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77
Resistance and susceptibility of mice to bacterial infection: course of listeriosis in resistant or susceptible mice. Infect Immun (1978) 2.65
Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis (2012) 2.52
Endogenous gamma interferon mediates resistance to Brucella abortus infection. Infect Immun (1993) 2.24
Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect Immun (1988) 2.04
In vivo and in vitro effects of monoclonal antibody to Ly antigens on immunity to infection. Cell Immunol (1982) 1.97
Resistance and susceptibility of mice to bacterial infection: histopathology of listeriosis in resistant and susceptible strains. Infect Immun (1980) 1.97
Restriction in adoptive transfer of resistance to Listeria monocytogenes. II. Use of congenic and mutant mice show transfer to be H-2K restricted. Cell Immunol (1983) 1.86
Macrophage behaviour during the complaisant phase of murine pertussis. Immunology (1969) 1.85
Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities. J Immunol (1982) 1.80
Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect Immun (1995) 1.70
A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J Immunol (1996) 1.67
Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis. J Immunol (1992) 1.64
Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes (CTL): possible implications for the affinity of CTL antigen receptors. Immunol Rev (1982) 1.63
Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October - December 2009. Euro Surveill (2010) 1.56
Macrophage activation during experimental murine brucellosis: a basis for chronic infection. Infect Immun (1979) 1.54
Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon. Clin Exp Immunol (1984) 1.51
The steady state in cellular immunity. II. Immunological complaisance in murine pertussis. Aust J Exp Biol Med Sci (1967) 1.49
Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis. Infect Immun (1993) 1.49
Cytokine response of T-cell subsets from Brucella abortus-infected mice to soluble Brucella proteins. Infect Immun (1993) 1.44
Colony-forming cells and colony-stimulating activity during listeriosis in genetically resistant or susceptible mice. Cell Immunol (1986) 1.43
Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect Immun (1996) 1.43
Expression of genes transferred to haemopoietic stem cells by recombinant retroviruses. Mol Biol Med (1987) 1.42
Recombinant interleukin-6 protects mice against experimental bacterial infection. Infect Immun (1992) 1.41
Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation. Euro Surveill (2011) 1.40
In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J Virol (1996) 1.39
Co-engagement of CD3 with LFA-1 or ICAM-1 adhesion molecules enhances the frequency of activation of single murine CD4+ and CD8+ T cells and induces synthesis of IL-3 and IFN-gamma but not IL-4 or IL-6. Int Immunol (1992) 1.37
A comparison of rapid point-of-care tests for the detection of avian influenza A(H7N9) virus, 2013. Euro Surveill (2013) 1.35
Resistance and susceptibility of mice to bacterial infection. IV. Genetic and cellular basis of resistance to chronic infection with Brucella abortus. J Infect Dis (1982) 1.34
Inflammatory response following intranasal infection with Mycobacterium avium complex: role of T-cell subsets and gamma interferon. Infect Immun (1995) 1.34
Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures. J Immunol (1984) 1.33
Differential activation of Brucella-reactive CD4+ T cells by Brucella infection or immunization with antigenic extracts. Infect Immun (1995) 1.33
Pathogenesis and cellular immunity in experimental murine brucellosis. Dev Biol Stand (1984) 1.32
Polyadenylic acid-polyuridylic acid (poly A : U) and experimental murine brucellosis. II. Macrophages as target cells of poly A : U in experimental brucellosis. Immunology (1978) 1.30
Cooperation between carrier-reactive and hapten-sensitive cells in vitro. Nat New Biol (1971) 1.30
The steady state in cellular immunity. I. Chemotherapy and superinfection in murine tuberculosis. Aust J Exp Biol Med Sci (1967) 1.27
Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors. J Immunol (1998) 1.27
Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection. Infect Immun (1995) 1.27
The in vitro bactericidal activity of peritoneal and spleen cells from Listeria-resistant and -susceptible mouse strains. Cell Immunol (1986) 1.25
Clonal heterogeneity in colony stimulating factor production by murine T lymphocytes. J Cell Physiol (1985) 1.22
Role of IL-6 in activation of T cells for acquired cellular resistance to Listeria monocytogenes. J Immunol (1994) 1.22
Secretion of interleukin 2, macrophage-activating factor, interferon, and colony-stimulating factor by alloreactive T lymphocyte clones. J Immunol (1984) 1.20
Enumeration of lymphokine mRNA-containing cells in vivo in a murine graft-versus-host reaction using the PCR. Proc Natl Acad Sci U S A (1992) 1.19
Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010. Euro Surveill (2011) 1.19
B lymphocytes as stimulators of a mixed lymphocyte reaction. Transplantation (1973) 1.18
Stimulator cell requirements for allospecific T cell subsets: specialized accessory cells are required to activate helper but not cytolytic T lymphocyte precursors. J Immunol (1983) 1.16
Contact sensitization to oxazolone: involvement of both interferon-gamma and interleukin-4 in oxazolone-specific Ig and T-cell responses. Immunology (1993) 1.15
Independent regulation of granulocyte-macrophage colony-stimulating factor and multi-lineage colony-stimulating factor production in T lymphocyte clones. J Immunol (1986) 1.14
Macrophage activation during experimental murine brucellosis. II. Inhibition of in vitro lymphocyte proliferation by brucella-activated macrophages. Cell Immunol (1980) 1.13
Cutting edge: stable epigenetic inheritance of regional IFN-gamma promoter demethylation in CD44highCD8+ T lymphocytes. J Immunol (1999) 1.13
Functionally distinct T cells in three compartments of the respiratory tract after influenza virus infection. Eur J Immunol (1996) 1.07
Glucocorticoid inhibition of lymphokine secretion by alloreactive T lymphocyte clones. J Immunol (1984) 1.05
Anergy, IFN-gamma production, and apoptosis in terminal infection of mice with Mycobacterium avium. J Immunol (1999) 1.05
Macrophage activation during experimental murine brucellosis. III. Do macrophages exert feedback control during brucellosis? Cell Immunol (1980) 1.04
Differential induction of macrophage-derived cytokines by live and dead intracellular bacteria in vitro. Infect Immun (1995) 1.01
Prophylaxis or treatment of experimental brucellosis with interleukin-1. Infect Immun (1991) 1.00
The impact of the pandemic influenza A(H1N1) 2009 virus on seasonal influenza A viruses in the southern hemisphere, 2009. Euro Surveill (2010) 0.99
Methodological issues in volumetric magnetic resonance imaging of the brain in the Edinburgh High Risk Project. Psychiatry Res (1999) 0.98
Mechanism of depletion of T lymphocytes from the spleen of mice infected with Listeria monocytogenes. Infect Immun (1982) 0.97
Characteristics of colony-stimulating factor production by murine T-lymphocyte clones. Exp Hematol (1985) 0.97
Effect of polyadenine: polyuridine on brucellosis in conventional and congenitally athymic mice. J Immunol (1974) 0.97
Activated T cells from draining lymph nodes and an effector site differ in their responses to TCR stimulation. J Immunol (1997) 0.96
Interaction of thymus lymphocytes with histoincompatible cells. IV. Mixed lymphocyte reactions of activated thymus lymphocytes. Cell Immunol (1974) 0.96
Differential activation of T cell cytokine production by the extracellular signal-regulated kinase (ERK) signaling pathway. Eur J Immunol (1996) 0.96
Comparison of thymic and peripheral T cell Ly-2/3 antigens. Eur J Immunol (1984) 0.95
The activated type 1-polarized CD8(+) T cell population isolated from an effector site contains cells with flexible cytokine profiles. J Exp Med (1999) 0.95
Listeriosis in beige mice and their heterozygous littermates. Immunology (1984) 0.95
The sequence of enhanced cellular activity and protective humoral factors in murine pertussis immunity. Immunology (1969) 0.95
Intranasal infection of beige mice with Mycobacterium avium complex: role of neutrophils and natural killer cells. Infect Immun (1996) 0.94
Cytolytic T lymphocyte clones. Immunobiology (1982) 0.94
Regulation of T cell cytokine production by dendritic cells. Immunol Cell Biol (2000) 0.93
A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy. Cancer Immunol Immunother (1997) 0.92
The cellular source of interleukin-6 during Listeria infection. Infect Immun (1993) 0.90
Resistance and susceptibility of mice to bacterial infection. IV. Functional specificity in natural resistance to facultative intracellular bacteria. J Reticuloendothel Soc (1983) 0.90
Delayed hypersensitivity in mature pulmonary pertussis. Aust J Exp Biol Med Sci (1969) 0.90
Activation of the extracellular signal-regulated kinase pathway is differentially required for TCR-stimulated production of six cytokines in primary T lymphocytes. Int Immunol (1998) 0.89